Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of “Moderate Buy” from Analysts

Stevanato Group S.p.A. (NYSE:STVN) has earned an average rating of “Moderate Buy” from the six ratings firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and five have issued a buy rating on the company.

Several equities analysts have recently issued reports on the company. Morgan Stanley reiterated an “equal weight” rating and set a $23.00 price objective (down from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Wolfe Research began coverage on Stevanato Group in a research report on Friday, December 13th. They set an “outperform” rating and a $28.00 price target for the company. Finally, Bank of America lifted their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Thrivent Financial for Lutherans acquired a new stake in Stevanato Group in the 2nd quarter valued at about $30,477,000. Pembroke Management LTD lifted its stake in Stevanato Group by 143.7% during the third quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock valued at $21,023,000 after purchasing an additional 619,747 shares during the last quarter. Tri Locum Partners LP bought a new stake in Stevanato Group during the second quarter worth approximately $10,370,000. Thornburg Investment Management Inc. grew its position in Stevanato Group by 279.1% in the second quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock worth $13,690,000 after buying an additional 549,378 shares during the last quarter. Finally, Conestoga Capital Advisors LLC increased its holdings in shares of Stevanato Group by 7.3% in the second quarter. Conestoga Capital Advisors LLC now owns 7,275,823 shares of the company’s stock valued at $133,439,000 after buying an additional 496,930 shares in the last quarter.

Stevanato Group Stock Performance

Shares of STVN opened at €21.34 ($22.23) on Friday. The stock has a market capitalization of $6.31 billion, a PE ratio of 45.40, a price-to-earnings-growth ratio of 10.49 and a beta of 0.59. The business’s fifty day moving average price is €20.01 and its 200 day moving average price is €19.76. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. Stevanato Group has a 12-month low of €16.56 ($17.25) and a 12-month high of €34.73 ($36.18).

Stevanato Group (NYSE:STVN) last posted its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million for the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period last year, the company posted $0.16 earnings per share. Equities research analysts forecast that Stevanato Group will post 0.5 EPS for the current year.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.